Treg infiltration in glioma: a hurdle for antiglioma immunotherapy

Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy

(2012) C. A. Crane et al.   NEURO-ONCOLOGY

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

(2011) Charlotte M Huijts et al.   BMC CANCER

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome

(2011) Yingzi Ge et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunotherapy for glioma

(2011) Gaetano Finocchiaro et al.   CURRENT OPINION IN NEUROLOGY

Mechanisms of immunomodulation in human glioblastoma

(2011) Tony Avril et al.   Immunotherapy

Immunomodulatory effects of cyclophosphamide and implementations for vaccine design

(2011) Antonella Sistigu et al.   Seminars in Immunopathology

Cyclophosphamide Induces Differentiation of Th17 Cells in Cancer Patients

(2010) S. Viaud et al.   CANCER RESEARCH

Phenotypic and functional switch of macrophages induced by regulatory CD4+ CD25+ T cells in mice

(2010) Guangwei Liu et al.   IMMUNOLOGY AND CELL BIOLOGY

Prognostic significance and mechanism of Treg infiltration in human brain tumors

(2010) Joannes F.M. Jacobs et al.   JOURNAL OF NEUROIMMUNOLOGY

Dendritic Cell Therapy of High-Grade Gliomas

(2009) Stefaan Van Gool et al.   BRAIN PATHOLOGY

DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma

(2009) Wim Maes et al.   NEURO-ONCOLOGY

The Role of Tregs in Glioma-Mediated Immunosuppression: Potential Target for Intervention

(2009) William Humphries et al.   NEUROSURGERY CLINICS OF NORTH AMERICA

Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas

(2008) A. B. Heimberger et al.   CLINICAL CANCER RESEARCH

Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study

(2007) Amy B. Heimberger et al.   NEURO-ONCOLOGY